TABLE I -.
Time to platelet count normalisation | Responder to treatment | |
---|---|---|
PEX and immunosuppression | Caplacizumab + PEX and immunosuppression | |
Weibull parameterisation | ||
Shape | 1.56 | 1.56-0.27 |
Scale | 0.68 | 0.68 |
Time to platelet count normalisation | Responder to treatment | |
---|---|---|
PEX and immunosuppression | Caplacizumab + PEX and immunosuppression | |
Weibull parameterisation | ||
Shape | 1.56 | 1.56-0.27 |
Scale | 0.68 | 0.68 |